High mobility box 1 mediates neutrophil recruitment in myocardial ischemia–reperfusion injury through toll like receptor 4-related pathway

HS Ding, J Yang, FL Gong, J Yang, JW Ding, S Li… - Gene, 2012 - Elsevier
HS Ding, J Yang, FL Gong, J Yang, JW Ding, S Li, YR Jiang
Gene, 2012Elsevier
This study aimed to explore the role of high mobility box 1 (HMGB1) and its receptor toll like
receptor 4 (TLR4) on neutrophils in myocardial ischemia reperfusion (I/R) injury. We
constructed TLR4-mutant (C3H/HeJ) and control (C3H/HeN) mouse models of myocardial
I/R injury and subjected the mice to 30min of ischemia and 6h of reperfusion. Light
microscope was used to observe structural changes in the myocardium. HMGB1 levels were
measured using quantitative real-time PCR and immunohistochemistry. Neutrophil …
This study aimed to explore the role of high mobility box 1 (HMGB1) and its receptor toll like receptor 4 (TLR4) on neutrophils in myocardial ischemia reperfusion (I/R) injury. We constructed TLR4-mutant (C3H/HeJ) and control (C3H/HeN) mouse models of myocardial I/R injury and subjected the mice to 30min of ischemia and 6h of reperfusion. Light microscope was used to observe structural changes in the myocardium. HMGB1 levels were measured using quantitative real-time PCR and immunohistochemistry. Neutrophil accumulation, TNF-a expression and IL-8 levels were analyzed via myeloperoxidase (MPO) biochemical studies, quantitative real-time PCR and ELISA, respectively. The results demonstrated that fewer neutrophils infiltrated in the myocardium of TLR4-mutant mice after myocardial I/R and that TLR4 deficiency markedly decreased the ischemic injury caused by ischemia/reperfusion, and inhibited the expression of HMGB1, TNF-a, and IL-8, all of which were up-regulated by ischemia/reperfusion. These findings suggest that HMGB1 plays a central role in recruiting neutrophils during myocardial I/R leading to worsened myocardial I/R injury. This recruitment mechanism is possibly due to its inflammatory and chemokine functions based on the TLR4-dependent pathway.
Elsevier